CEP-32496 is a potent inhibitor of BRAF (V600E/WT) and c-Raf, with Kd values of 14 nM, 36 nM, and 39 nM, respectively; it also shows moderate activity against Abl-1, c-Kit, Ret, PDGFRβ, and VEGFR2, and weak affinity for MEK-1, MEK-2, ERK-1, and ERK-2. As a multi-kinase inhibitor, CEP-32496 exhibits broad-spectrum antitumor and anti-angiogenic effects and is under development for the treatment of various cancers.